Azacitidine treatment toxicities

Rena Buckstein, MD, FRCPC, Odette Cancer Research Program, Sunnybrook Research Institute, Toronto, Canada, discusses some of the toxicities associated with azacitidine in the treatment of higher-risk myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). This interview took place at the 2nd Regional Symposium on Myelodysplastic Syndromes (MDS 2020), held in Tel Aviv, Israel.

• #education
• #speaker_rena_buckstein
• #institution_odette_cancer_research_program
• #sunnybrook_research_institute
• #event_mds_2020
• #format_interview
• #subject_myelodysplastic_syndromes
• #medicines_azacitidine
• #field_treatment
• #field_trial_updates
• #toxicities